Psychedelics Therapy More Than Just a Quick Fix

Effect of psychedelics treatment goes beyond the immediate mental health diagnosis.

For years, medical professionals have been treating their patients with a series of drugs and therapies with limited ongoing success. So it’s no wonder that the psychedelics renaissance gaining prominence in mental health circles has definitely caught their attention.

An estimated 350 million individuals experience depression annually. It takes, on average, almost 10 years to obtain treatment after symptoms begin, and more than two-thirds of depressed individuals never receive adequate care.

Many commonly prescribed psychotropic medications, including antidepressants and antipsychotics, are associated with serious adverse effects, including weight gain, increased risk of diabetes and heart disease, neurologic disorders, and sudden cardiac death.

One study found that, in many psychiatric disorders, habits of mind and behavior, as well as beliefs, become “too precise,” meaning they are rigidly encoded and too influential. Examples include the negative cognitive bias in depression, specific cravings in addictions, specific fears in anxiety disorders, specific obsessions in obsessive compulsive disorder and specific bodily beliefs in body image disorders.

Psychedelics therapy has the promise of providing a safer avenue of ongoing holistic treatment and personal lifestyle development than traditional treatments.

While psychedelics clinical trials are still relatively small, there are more of them each year, using mostly classic psychedelics. Results have been encouraging. Some clinical trials continue to follow participants after conclusion of the trial – up to 12 months and still going – to see if the positive results continue.

But truth be told, this is still a young industry. Research and development is expensive, and there is still much to find out. Few companies have revenue to show for their work so far. And FDA approval for any psychedelic beyond ketamine is still years away.

Psychedelics therapy so far is not about taking a pill – though that is coming. It’s about a combination of psychotherapy with a psychedelic compound in a monitored set and setting that takes hours and sometimes days or even weeks to be effective.

Psychedelic compounds such as LSD, psilocybin, and DMT may not seem like obvious tools for promoting healthier living. However, plants and fungi with psychedelic potential have been used by humans for centuries, if not millennia, for holistic “healing” of body and mind. Modern psychedelics research is working on that angle as well.

The data is revealing that psychedelics for treating mental health issues can be more than just a quick fix. It becomes a larger lifestyle fix.

In a recent observational study, 380 ayahuasca users were asked about their health (including height and weight, allowing for calculation of their body mass index (BMI), and their physical activity, diet, and yoga/meditation habits).

When compared to data from the general population, results showed that ayahuasca users had a mean BMI of 22.6 kg/m2, well below the 30 kg/m2 cut-off for obesity and clearly lower than that of the general Spanish population. These users also had a high fruit and vegetable consumption (with 60-75% ingesting 3-6 servings a day of each vs. 22-48% in the general population).

In a U.S. survey of 343 people who claimed to have stopped or reduced alcohol consumption and misuse after a psychedelic experience, 63% of the participants also endorsed “improved diet,” and 55% reported “increased exercise” as a result of their psychedelic experience.

In a similar study of 444 participants who claimed to have stopped or reduced cannabis, opioid, or stimulant misuse after a psychedelic experience, 59% endorsed “improved diet” and 58% endorsed “increased exercise” as a result of their psychedelic experience.

The Johns Hopkins’ initial and follow-up studies on smoking cessation also provided evidence that participants were making other positive changes in their lives (besides reducing smoking) as they went through the psilocybin-assisted therapy program. Both studies reported significant (51%) increases in a self-reported scale titled “positive behavior changes” as people moved from baseline to the end of the treatment.

These were described further in a qualitative analysis, according to the study, which reported increases in time spent in nature, taking time for oneself, prosocial behaviors such as volunteering and joining community groups, and greater engagement with art.

A similar pattern was observed in the study of psilocybin for depression in cancer patients, from the same research group.

Although these are not health-related behaviors, results suggest psychedelics may be associated with life changes consistent with improved well-being and meaning. In support of this, a recent 4.5-year follow-up of cancer patients who underwent psilocybin-assisted therapy showed persisting increases in not just well-being/life satisfaction (reported by 86% of participants) but also in “positive behavior changes” attributed to the psilocybin experience.

In a perspective published in Frontiers in Psychiatry magazine, researchers from UCLA Health and Harvard Medical School coin the term “behavioral psychedelics” – the study of psychedelics to foster intentional changes in habits and behaviors to improve health and resilience. “Behavioral psychedelics can realize this potential by developing targeted approaches for therapeutic change that help people achieve enduring functional improvements in self-care, social connection, and family, school, and community responsibilities to help them live the life they desire,” the researchers reported.

“Studies should expand existing research to look at broader ranges of behavioral targets including diet, exercise, and other ‘wellness behaviors,’” research published in the Journal of Psychopharmacology concluded.

“If psychedelic-assisted therapy is found to work through general processes, such as relaxed beliefs, psychological flexibility, and self-determined motivation, this might be used to enhance behavior change across a number of disorders and lifestyle challenges, and enhance the effects of multiple psychotherapeutic approaches. This would constitute a shift to a fuller transdiagnostic understanding of psychiatric disorders along a continuum with normative human behavior and lifestyle challenges.”

Dave Hodes

David Hodes is a business journalist based in the Washington D.C. metropolitan area. He has contributed feature articles to several cannabis and psychedelics publications, as well as general business/lifestyle publications, on a variety of topics. Hodes was selected as 2018 Journalist of the Year by Americans for Safe Access. He is a member of the National Press Club, and the deputy booking agent for the National Press Club Headliners Committee.


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 4 hours

Despite Early Access for Out-of-State Brands, In-State Hope Remains

@GreenMarketRpt – 4 hours

Out-of-State Brands Already Entering New York Cannabis Market

@GreenMarketRpt – 3 days

Georgia Medical Cannabis Program Rules Delayed over Technicality

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.